NCT01718223View on ClinicalTrials.gov

Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Recurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the OropharynxRecurrent Verrucous Carcinoma of the Oral CavityStage I Squamous Cell Carcinoma of the Lip and Oral CavityStage I Squamous Cell Carcinoma of the OropharynxStage I Verrucous Carcinoma of the Oral CavityStage II Squamous Cell Carcinoma of the Lip and Oral CavityStage II Squamous Cell Carcinoma of the OropharynxStage II Verrucous Carcinoma of the Oral CavityTongue Cancer
Interventions
DRUG

photodynamic therapy

Undergo interstitial photodynamic therapy using temoporfin

PROCEDURE

therapeutic conventional surgery

Undergo surgical resection

OTHER

laboratory biomarker analysis

Correlative studies

DRUG

temoporfin

Undergo interstitial photodynamic therapy using temoporfin

Sponsors

Collaborators (1)

Biolitec Pharma Ltd.
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Biolitec Pharma Ltd.

INDUSTRY

lead

Roswell Park Cancer Institute

OTHER

NCT01718223 - Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer | Biotech Hunter | Biotech Hunter